Business · 28/05/2024Updated: 10/17/2026 · 1 min read
FDA Authorizes Emergency Use of Drug Product PEMGARDA for COVID-19 Treatment
Summary
The US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the drug product PEMGARDA (pemivibart) to treat COVID-19, following a public health emergency declaration by the Secretary of Health and Human Services in March 2020.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →